Published in Hepatitis Weekly, October 20th, 2008
"The present study was conducted to evaluate the genomic fragments of HAV, spanning from the 5'NCR to 3'NCR to employ them in molecular diagnosis and genotyping. The different phylogenetic methods confirmed the use of the 5'NCR and the VP4 region in diagnosis...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.